InvestorsObserver is giving Arcturus Therapeutics Holdings Inc (ARCT) an Analyst Rating Rank of 25, meaning ARCT is ranked higher by analysts than 25% of stocks. The average price target for ARCT is $85.727 and analyst’s rate the stock as a Buy
Why are Analyst Ratings Important?
You can learn a lot about a company from looking at it’s financial statements and comparing them to other companies. Analysts who cover an industry in depth can add even more to your research though. They typically follow a particular sector or industry very closely. They also pay attention to and ask questions on earnings conference calls and other events where they might learn information that does show up in the numbers.
InvestorsObserver takes the average rating from these analysts, and then percentile ranks those averages. This lets you compare stocks in a much more granular way than just seeing the typical five-tiered rating system used on most of Wall Street.
What's Happening With Arcturus Therapeutics Holdings Inc Stock Today?
Arcturus Therapeutics Holdings Inc (ARCT) stock is trading at $54.61 as of 3:16 PM on Tuesday, Mar 2, a drop of -$0.03, or -0.05% from the previous closing price of $54.64. Volume today is light. So far 465,549 shares have traded compared to average volume of 1,177,515 shares. The stock has traded between $53.34 and $57.24 so far today.
Click Here to get the full report on Arcturus Therapeutics Holdings Inc (ARCT) Stock.
